ACT Capital Management »

Regenxbio Inc equity us cm shares owned by ACT Capital Management

Quarter-by-quarter ownership of Regenxbio Inc equity us cm (RGNX) shares owned by ACT Capital Management from 13F filings

Historical chart of ACT Capital Management investment in Regenxbio Inc equity us cm

Tip: Access up to 7 years of quarterly data

All positions including Regenxbio Inc equity us cm held by ACT Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regenxbio Inc equity us cm by ACT Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.2M 83k 14.40

More positions owned by ACT Capital Management

Krystal Biotech (KRYS)
Chevron Corporation (CVX)
Exxon Mobil Corporation (XOM)
Abivax Sponsored Ads (ABVX)
Tg Therapeutics (TGTX)
Viking Therapeutics (VKTX)
Celcuity (CELC)
Amazon (AMZN)
Nuvation Bio Com Cl A (NUVB)
Arrowhead Pharmaceuticals (ARWR)
Cytokinetics (CYTK)
Celcuity Inc Com Mar 20 26 $50 Call Option
Structure Therapeutics Sponsored Ads (GPCR)
Grayscale Bitcoin Trust Etf Shs Rep Com Ut (GBTC)
Figure Technology Solutions Com Cl A (FIGR)

View all positions for ACT Capital Management

Top funds holding Regenxbio Inc equity us cm

BlackRock
Redmile Group
Jpmorgan Chase & Co
Vanguard Group
State Street Corporation
Goldman Sachs Group
AQR Capital Management
Integral Health Asset Management
Assenagon Asset Management
Geode Capital Management
22NW
Dimensional Fund Advisors
Nuveen
Pale Fire Capital SE
Qube Research & Technologies

View all funds holding Regenxbio Inc equity us cm